[Individual therapeutic procedure in metastatic carcinoid of the small intestine].
Actually, the therapeutic goal in a metastasized carcinoid tumor is rather symptomatic than curative. Here we report the case of a 53 year old woman with a hepatic and pulmonal metastasized carcinoid tumor of the small intestine. We will discuss current therapeutic options and the approach to the individual patient. After treatment with the standard therapeutics Octreotide and Interferon alpha we could achieve a remarkable and persistent remission by applying the rather unusual drug Dacarbacine in this patient. This is an example for the frequently occurring clinical situation in the treatment of patients with rare tumors requiring the application of individually modified therapeutic regimens. Furthermore, the potency of Dacarbacine in the treatment of carcinoid tumors seems to be underestimated up to now.
Barthel
A
A
Zentrum Innere Medizin, Georg-August-Universität Göttingen.
Leonhardt
U
U
Stöckmann
F
F
Ramadori
G
G
D002276:Carcinoid Tumor / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D003082:Colectomy; D003131:Combined Modality Therapy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007078:Ileal Neoplasms / Q000473:pathology / Q000628:therapy*; D016898:Interferon-alpha / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D008175:Lung Neoplasms / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D008207:Lymphatic Metastasis; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*
D016898:Interferon-alpha; D015282:Octreotide; D005472:Fluorouracil
Individuelles therapeutisches Vorgehen beim metastasierten Dünndarmkarzinoid.